Tag: Clinical Trials

What Are the Benefits of CBD?

The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, conducted by the Brightfield Group, a […]

Read More

Scientist Who Discredited Meat Guidelines Didn’t Report Past Food Industry Ties

A surprising new study challenged decades of nutrition advice and gave consumers the green light to eat more red and processed meat. But what the study didn’t say is that its lead author has past research ties to the meat and food industry. The new report, published this week in the Annals of Internal Medicine, […]

Read More

Asthma 3-in-1 Therapy May Improve Lung Function, Study Shows

Many people with asthma use inhalers to control the chronic inflammation in their lungs. But for those with more severe forms of the disease, the standard inhaled medication may not be enough to keep the wheezing, chest tightness and attacks at bay. Now, a new combination-therapy — using three drugs in a single inhaler — […]

Read More

Eat Less Red Meat, Scientists Said. Now Some Believe That Was Bad Advice.

Public health officials for years have urged Americans to limit consumption of red meat and processed meats because of concerns that these foods are linked to heart disease, cancer and other ills. But on Monday, in a remarkable turnabout, an international collaboration of researchers produced a series of analyses concluding that the advice, a bedrock […]

Read More

Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets

Twenty years ago, the fight against cancer seemed as if it were about to take a dramatic turn. Traditionally, cancer doctors fought the disease with crude weapons, often simply poisoning fast-growing cells whether they were cancerous or healthy. But then a team of researchers hit on a new strategy: drugs targeting proteins produced by cancer […]

Read More

Who’s Missing From Breast Cancer Trials? Men, Says the F.D.A.

In recent years, health officials have pushed aggressively to include more women in clinical trials of new drugs. Gone is the ban that once excluded women of childbearing age from participating in studies. Even scientists who work with animals are now encouraged to include mice and rats of both sexes. But when it comes to […]

Read More

Scientists Discover a Cure for the Deadliest Strain of Tuberculosis

TSAKANE, South Africa — When Tsholofelo Msimango joined a clinical trial of new tuberculosis drugs, she was 20 years old and weighed just 57 pounds. Stricken with a deadly strain of tuberculosis, Ms. Msimango was terrified. She was to be transferred to Sizwe Tropical Diseases Hospital in Johannesburg. The nurses in the township here told […]

Read More

This Drug Will Save Children’s Lives. It Costs $2 Million.

Spinal muscular atrophy is a condition often fatal by age 2. Babies with the disorder have a rare genetic mutation that prevents the nervous system from controlling certain muscles. As they grow to be toddlers, these children struggle to move their limbs, to swallow food, to talk. The Food and Drug Administration recently approved a […]

Read More

A Blood Test for Alzheimer’s? It’s Coming, Scientists Report

For decades, researchers have sought a blood test for beta amyloid, the protein that is a hallmark of Alzheimer’s disease. Several groups and companies have made progress, and on Thursday, scientists at Washington University in St. Louis reported that they had devised the most sensitive blood test yet. The test will not be available for […]

Read More

10 Medical Myths We Should Stop Believing. Doctors, Too.

You might assume that standard medical advice was supported by mounds of scientific research. But researchers recently discovered that nearly 400 routine practices were flatly contradicted by studies published in leading journals. Of more than 3,000 studies published from 2003 through 2017 in JAMA and the Lancet, and from 2011 through 2017 in the New […]

Read More

This Drug Could End H.I.V. Why Hasn’t It?

Listen and subscribe to our podcast from your mobile device: Via Apple Podcasts | Via RadioPublic | Via Stitcher Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened. [For an exclusive look at how […]

Read More

Half of H.I.V. Patients Are Women. Most Research Subjects Are Men.

Inspired by reports of a second patient apparently freed of infection with H.I.V., the virus that causes AIDS, scientists are pursuing dozens of ways to cure the disease. But now, researchers must reckon with a longstanding obstacle: the lack of women in clinical trials of potential H.I.V. treatments, cures and vaccines. Women make up just […]

Read More